Lower Inpatient Costs for Dabigatran, Rivaroxaban in A-Fib
Lower inpatient costs with dabigatran, rivaroxaban versus warfarin for newly diagnosed atrial fibrillation
ACP, AAFP Raise BP Rx Threshold for Healthy Adults Over 60
Guideline says therapy should begin after systolic BP meets or exceeds 150 mm Hg, not 140
Physician Excess Charges Create Financial Burden for Patients
Fees affect uninsured Americans, privately insured patients who use out-of-network physicians
BNP, Gal-3 Levels Predict 60-Day Readmission in Heart Failure
Addition of Gal-3 to BNP significantly improves prediction in acute decompensated heart failure
Heart Rate Variability Linked to Atrial Fibrillation
Lower HRV, increased sympathetic/parasympathetic tone linked to higher risk of a-fib
Caffeine Found to Reduce Age-Related Inflammation
Connection between advancing age, systemic inflammation, cardiovascular disease and caffeine
Tobacco Counseling for Youth, Adults Cuts Smoking Prevalence
Annual counseling would reduce prevalence and prevent many smoking-attributable fatalities
Left Ventricular Assist Device Ups QoL in Ambulatory Heart Failure
Left ventricular assist devices increase quality-adjusted life-years, readmissions, and costs
Sitagliptin Has Neutral CV Risk Effect in Elderly With T2DM, CVD
Neutral effects on cardiovascular risk among older patients with well-controlled T2DM and CVD
β-Blockers Linked to Reduced Mortality in HFrEF, A-Fib
Reduction in all-cause mortality, but not hospitalization, regardless of pattern, burden of a-fib
